These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 21591359
1. [The plasma levels and diagnostic utility of selected hematopoietic growth factors (HGFs) in breast cancer patients]. Ławicki S, Czygier M, Wojtukiewicz M, Szmitkowski M. Przegl Lek; 2010; 67(12):1314-8. PubMed ID: 21591359 [Abstract] [Full Text] [Related]
2. [The plasma levels and diagnostic utility of granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage - colony stimulating factor (GM-CSF) in patients with I and II stage of breast cancer]. Ławicki S, Czygier M, Wojtukiewicz M, Szmitkowski M. Przegl Lek; 2009; 66(7):365-9. PubMed ID: 20043577 [Abstract] [Full Text] [Related]
3. [The plasma levels and diagnostic utility of selected hematopoietic growth factors in endometrial cancer patients and with myoma uteri]. Ławicki S, Bedkowska GE, Gacuta-Szumarska E, Czygier M, Szmitkowski M. Pol Merkur Lekarski; 2010 May; 28(167):354-8. PubMed ID: 20568396 [Abstract] [Full Text] [Related]
4. [The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients]. Ławicki S, Czygier M, Omyła J, Bedkowska E, Szmitkowski M. Pol Merkur Lekarski; 2007 Oct; 23(136):259-63. PubMed ID: 18293847 [Abstract] [Full Text] [Related]
5. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients. Ławicki S, Szmitkowski M, Wojtukiewicz M. Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152 [Abstract] [Full Text] [Related]
6. [The plasma levels and diagnostic utility of granulocyte colony stimulating factor (G-CSF) and macrophage - colony stimulating factor (M-CSF) in ovarian cancer patients]. ławicki S, Czygier M, Gacuta-Szumarska E, Knapp P, Szmitkowski M. Pol Merkur Lekarski; 2006 Nov; 21(125):465-8. PubMed ID: 17345841 [Abstract] [Full Text] [Related]
7. [The plasma levels and diagnostic utility of stem cell factor (SCF) and macrophage-colony stimulating factor (M-CSF) in cervical cancer patients]. Lawicki S, Bedkowska E, Gacuta-Szumarska E, Knapp P, Szmitkowski M. Pol Merkur Lekarski; 2008 Jul; 25(145):38-42. PubMed ID: 18839612 [Abstract] [Full Text] [Related]
8. Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients. Ławicki S, Będkowska GE, Wojtukiewicz M, Szmitkowski M. Adv Med Sci; 2013 Jul; 58(2):207-15. PubMed ID: 23846151 [Abstract] [Full Text] [Related]
9. Hematopoietic cytokines as tumor markers in gynecological malignancies: a multivariate analysis with ROC curve in endometrial cancer patients. Lawicki S, Będkowska GE, Gacuta-Szumarska E, Szmitkowski M. Growth Factors; 2012 Feb; 30(1):29-36. PubMed ID: 22010785 [Abstract] [Full Text] [Related]
10. [The plasma levels and diagnostic utility of stem cell factor and macrophage--colony stimulating factor in endometrial cancer patients]. Lawicki S, Bedkowska E, Gacuta-Szumarska E, Czygier M, Szmitkowski M. Przegl Lek; 2007 Feb; 64(12):987-90. PubMed ID: 18595499 [Abstract] [Full Text] [Related]
11. [The plasma levels and diagnostic utility of stem cell factor in patients with endometrial cancer and myoma uteri]. Ławicki S, Bedkowska GE, Gacuta-Szumarska E, Czygier M, Szmitkowski M. Pol Merkur Lekarski; 2009 Jun; 26(156):609-15. PubMed ID: 19711726 [Abstract] [Full Text] [Related]
12. [Selected hematopoietic cytokines in patients with colorectal cancer]. Mroczko B, Ławicki S, Szmitkowski M, Czygier M, Okulczyk B, Piotrowski Z. Pol Merkur Lekarski; 2003 Nov; 15(89):416-9. PubMed ID: 14969133 [Abstract] [Full Text] [Related]
13. Hematopoietic growth factors in colorectal cancer patients. Mroczko B, Szmitkowski M, Okulczyk B. Clin Chem Lab Med; 2003 May; 41(5):646-51. PubMed ID: 12812262 [Abstract] [Full Text] [Related]
14. Hematopoietic cytokines in the sera of patients with pancreatic cancer. Mroczko B, Szmitkowski M, Wereszczyńska-Siemiatkowska U, Jurkowska G. Clin Chem Lab Med; 2005 May; 43(2):146-50. PubMed ID: 15843207 [Abstract] [Full Text] [Related]
15. [The plasma levels of granulocyte-colony stimulating factor (G-CSF) and macrophage-colony stimulating factor (M-CSF) in breast cancer patients]. Lawicki S, Czygier M, Omyła J, Szmitkowski M. Pol Arch Med Wewn; 2006 Aug; 116(2):749-55. PubMed ID: 17424919 [Abstract] [Full Text] [Related]
16. Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer. Ławicki S, Głażewska EK, Sobolewska M, Będkowska GE, Szmitkowski M. Ann Lab Med; 2016 May; 36(3):223-9. PubMed ID: 26915610 [Abstract] [Full Text] [Related]
17. VEGF, M-CSF and CA 15-3 as a new tumor marker panel in breast malignancies: a multivariate analysis with ROC curve. Ławicki S, Będkowska GE, Szmitkowski M. Growth Factors; 2013 Jun; 31(3):98-105. PubMed ID: 23688065 [Abstract] [Full Text] [Related]
18. Plasma Levels and Diagnostic Utility of M-CSF, MMP-2 and its Inhibitor TIMP-2 in the Diagnostics of Breast Cancer Patients. Ławicki S, Zajkowska M, Głażewska EK, Będkowska GE, Szmitkowski M. Clin Lab; 2016 Sep 01; 62(9):1661-1669. PubMed ID: 28164586 [Abstract] [Full Text] [Related]
19. The diagnostic value of G-CSF measurement in the sera of colorectal cancer and adenoma patients. Mroczko B, Groblewska M, Wereszczynska-Siemiatkowska U, Kedra B, Konopko M, Szmitkowski M. Clin Chim Acta; 2006 Sep 01; 371(1-2):143-7. PubMed ID: 16603145 [Abstract] [Full Text] [Related]
20. Comparative evaluation of plasma levels and diagnostic values of macrophage-colony stimulating factor in patients with breast cancer and benign tumors. Ławicki S, Czygier M, Bedkowska E, Wojtukiewicz M, Szmitkowski M. Pol Arch Med Wewn; 2008 Sep 01; 118(9):464-9. PubMed ID: 18846980 [Abstract] [Full Text] [Related] Page: [Next] [New Search]